Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Pliant Therapeutics Inc
PLRXCurrent price
12.43 USD
-0.47 USD (-3.64%)
Last closed
12.85 USD
Company
pliantrx.com
ISIN
US7291391057
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
912 803 968 USD
Yield for 12 month
-7.93 %
1Y
3Y
5Y
10Y
15Y
PLRX
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California. Address: 260 Littlefield Avenue, South San Francisco, CA, United States, 94080
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
40.18 USDP/E ratio
–Dividend Yield
–Current Year
+1 580 000 USD
Last Year
+9 685 000 USD
Current Quarter
–
Last Quarter
–
Current Year
-261 000 USD
Last Year
+6 004 000 USD
Current Quarter
–
Last Quarter
-622 000 USD
Key Figures PLRX
1 year
3 years
5 years
10 years
EBITDA
-219 951 008 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.15 %
PEG Ratio
–
Return On Equity TTM
-47.52 %
Wall Street Target Price
40.18 USD
Revenue TTM
–
Book Value
5.68 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
9 685 000 USD
Earnings per share
-3.35 USD
Diluted Eps TTM
-3.35 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics PLRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PLRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation PLRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1376.695
Price Sales TTM
3050.3447
Enterprise Value EBITDA
-2.5371
Price Book MRQ
2.6395
Financials PLRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PLRX
For 52 weeks
10.22 USD
19.62 USD
50 Day MA
13.03 USD
Shares Short Prior Month
6 767 543
200 Day MA
13.57 USD
Short Ratio
15.47
Shares Short
6 950 795
Short Percent
11.68 %
BeatStart